HEALTHCARE, SCIENCE & EDUCATION Global Life Sciene Company SPEAKER PROFILE KEY COMPANY FACTS • Saskia Steinacker was named Global Head of Digital Key Corporate Facts Valuation Data and Key Financials Excellence in February 2017. In this capacity, she Headquarters Leverkusen, Germany Market Cap €87.2bn leads Bayer’s digital transformation in close collaboration with the Board of Management. Together Founded 1863 with the divisions and functions she developed the 2017 2018E Growth company’s Digital Agenda with a focus on new Revenues €m 35,015 35,341 1% business models to accelerate new growth Employees 99,820+ • From 2013-2016 she lead the global digital IT function Active Markets Global EBITDA €m 8,801 9,443 7% for Bayer and prior to this the Bayer North America Marketing & Sales IT unit Ownership Public (ETR) Margin % 25% 27% - Saskia • In 2004 she joined Bayer and held a succession of roles in Marketing, ranging from Multichannel Marketer Steinacker Temasek, Vanguard Group, EV/Revenue 2.5x 2.5x (0%) to Head of Dialog Marketing for Diabetes Care. In this Key Shareholders NBIM, BlackRock Global Head of capacity she redesigned the customer interaction of Digital the unit and launched a state-of the art CRM program. Investor Click here to download EV/EBITDA 9.5x 9.4x (1%) Presentations Excellence • She graduated from Ecosign Academy with a degree in Communication Design and holds a Master in Website bayer.com Business Administration from Liverpool University COMPANY PROFILE BAYER @ NOAH Doing Business @ NOAH Main Presentation Topics • Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative Women in Healthcare Panel Discussion products, we are contributing to finding solutions to some of the major Service Provider Interest with and Simone Menne challenges of our time Business Intelligence • Together, the Life Science businesses make up a strong, attractive and CI & Data Science balanced portfolio that is resistant to fluctuations in demand and to potential risks. Our operations are managed in three divisions – Pharmaceuticals, Consumer Health and Crop Science – and the Animal Health business unit, which are also reporting segments Attendees @ NOAH Saskia Steinacker, Global Head of Digital Excellence All financial actual data and estimates provided by CapitaIQ, as of 06/05/2018. 20